NeuroPace(NPCE)
MOUNTAIN VIEW, CAMedical Devices
Focus: NeuroPace is a publicly traded medical device company specializing in implantable neuromodulation systems, primarily focused on epilepsy treatment through its flagship RNS System.
Profile data last refreshed 5h ago · AI intelligence enriched 10h ago
Funding Stage
PUBLIC
Open Jobs
6+3 this month
Stable — net +3 jobs in 30d
4 added, 1 removed. Backfill posture.
Should You Work at NeuroPace?
AI assessmentNeuroPace offers meaningful device-focused neurology experience and growth optionality, but tight cash burn and sparse hiring suggest timing risk for job security and advancement.
Why Work Here
- Focused pipeline with multiple epilepsy indications in Phase 2–4 development plus emerging indication in loss-of-control eating, signaling expansion beyond core neurology market
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$80M
Pipeline & Clinical Trials
electrical stimulation
EpilepsyClinical Trials (1)
NCT02781129Navigation and Free Recall in Chronically Implanted Humans
N/AHelp build intelligence for NeuroPace
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.